GP

Guangdong Provincial People's Hospital at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Guangdong Provincial People's Hospital takes part in 6 sessions at ESMO 2026 in Madrid. Its sessions focus on when surgery and other local treatments help in advanced lung cancer, and on how cancer drug development moves from China to the world. It also reports prospective validation of an agentic artificial intelligence system supporting multidisciplinary decisions in perihilar cholangiocarcinoma, a bile duct cancer.

OrganizationESMO 2026 Attendance
GP
Guangdong Provincial People's Hospital
Guangzhou, China
Cancer centre & hospital
Provincial general hospital in Guangzhou, China, part of the Guangdong Academy of Medical Sciences and home to the Guangdong Lung Cancer Institute.
Abstract
Fri Oct 23
14:32–14:37
702RO - Immune checkpoint blockade for patients with leptomeningeal metastases from non-small cell lung cancer
Rapid oral: CNS tumours
Sarcoma, CNS, head & neck and rare cancers
Chair
Fri Oct 23
16:15–17:30
Optimising use of local therapy in advanced lung cancer: Why, when, and how
with Hospital Universitario Puerta de Hierro Majadahonda
Lung & thoracic cancers
Talk
Fri Oct 23
16:15–16:20
Presentation of case/condition
Optimising use of local therapy in advanced lung cancer: Why, when, and how
Lung & thoracic cancers
Talk
Fri Oct 23
17:00–17:20
Surgery perspective
Optimising use of local therapy in advanced lung cancer: Why, when, and how
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Guangdong Provincial People's Hospital

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction